Proliferative vitreoretinopathy: Risk factors and pathobiology

Progress in Retinal and Eye Research

Volumn 21, Issue 1, 2002, Pages 127-144

  Pastor, J Carlos ^a   De La Rúa, E Rodríguez ^a   Martín, Francisco ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Chronobiology; Clinical risk factors; Pathobiology; Proliferative vitreoretinopathy; PVR

Indexed keywords

COLLAGEN; CYTOKINE; GROWTH FACTOR;

ARTICLE; CELL INTERACTION; CELL TYPE; CHRONOBIOLOGY; CLINICAL RESEARCH; EPIRETINAL MEMBRANE; EXTRACELLULAR MATRIX; EYE INFLAMMATION; FIBROBLAST; GLIA CELL; HUMAN; IMAGE ANALYSIS; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA DETACHMENT SURGERY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; VITREORETINOPATHY;

EID: 0036127722     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(01)00023-4     Document Type: Review

References (113)

1. Incidencia de la vitreorretinopatía proliferante (VRP) en el desprendimiento de retina regmatógeno
2. Factor influencing anatomic and visual results in primary scleral buckling
3. Grierson I. Oxytalan fibres in proliferative vitreoretinopathy
4. Retinal detachment in the cat: The pigment epithelial-photoreceptor interface
5. How to predict proliferative vitreoretinopathy. A prospective study
6. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy
7. Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy
8. La proliferation vitreoretinienne. I. Aspects clinicopathologiques
9. TGF-b1, TGFb receptor II and DE-A fibronectin expression in myofibroblasts of vitreoretinopathy
10. The development of severe proliferative vitreoretinopathy after retinal detachment surgery, grade B: A determining risk factor
11. Cryopexy in primary rhegmatogenous retinal detachment: A risk factor for postoperative proliferative vitreoretinopathy?
12. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
13. Localization of platelet osteonectin at the internal face of the α-granule membranes in platelets and megakaryocytes
14. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease
15. Autoimmune responsiveness to retinal IRBP, S-antigen and opsin in proliferative vitreoretinopathy
16. Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy
17. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction
18. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy
19. Valoración densitométrica de la fibronectina y la vitronectina intravítreas en las enfermedades proliferativas intraoculares
20. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in RPE
21. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders
22. Proliferative vitreoretinopathy: Pathobiology, surgical management, and adjunctive treatment
23. Growth factors in proliferative vitreoretinopathy
24. Proliferative vitreoretinopathy: Lymphocytes in epiretinal membranes
25. Inflammatory cells in proliferative vitreoretinopathy subretinal membranes
26. Estudio citológico del vítreo en las vitrectomías: Diferencias entre la vitreorretinopatía proliferante y la retinopatía diabética proliferante
27. Clinico-pathologic correlation of vitreous membranes
28. Comparison of flow cytometry with the surgeon regarding ability to predict the ultimate success of surgery for proliferative vitreoretinopathy
29. Clinical risk factors for proliferative retinopathy
30. Choroidal detachment associated with rhegmatogenous retinal detachment: A risk factor for postoperative PVR
31. Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment a risk factor for postoperative proliferative vitreoretinopathy?
32. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy
33. Modulation and function of ICAM-1 (CD54) on human RPE
34. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy
35. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: Differentiation of subpopulations
36. Cellular effects of detachment on the neural retina and the retinal pigment epithelium
37. Intraretinal proliferation induced by retinal detachment
38. Electrophysiology of rabbit Müller (Glial) cells in experimental retinal detachment and PVR
39. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study
40. Pseudophakic retinal detachment: Anatomic and visual results
41. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery
42. Surgery for proliferative vitreoretinopathy
43. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction
44. Creación de un modelo eficaz de VRP
45. Hepatocyte growth factor/scatter factor in the eye
46. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy
47. A multivariate analysis of the anatomic success of retinal detachments treated with scleral buckling
48. Retinal and epiretinal glia. An immunohistochemical study
49. Thrombospondin as a component of the extracellular matrix of epiretinal membranes: Comparison with cellular fibronectin
50. Local production of fibronectin by ectopic human retinal cells
51. Matrix and the retinal pigment epithelium in proliferative retinal disease
52. Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease
53. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor
54. Proliferative vitreoretinopathy membranes. An immunohistochemical study
55. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy
56. Expression of vitreous cytokines in proliferative vitreoretinopathy: A prospective study
57. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: A prospective study
58. Massive periretinal proliferation: IV. Pre and subretinal proliferation of glial tissue in experimental retinal detachment
59. Glial cell proliferation in retinal detachment (massive periretinal proliferation)
60. Hepatocyte growth factor receptor in human rpe cells: Implications in proliferative vitreoretinopathy
61. Classification of proliferative vitreoretinopathy used in the silicone study
62. Epitheliomesenchymal transdifferentiation of cultured RPE cells
63. Inhibition of growth factor effects in RPE
64. Subretinal membranes in proliferative vitreoretinopathy
65. Vitreous levels of intracellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy
66. Factores clínicos de riesgo de la vitreoretinopatía proliferativa después de la cirugía del desprendimiento de retina
67. Surgical approaches to subretinal strands
68. An update classification of retinal detachment with proliferative vitreoretinopathy
69. Tractional force generation by porcine müller cells: Paracrine stimulation by retinal pigment epithelium
70. Migration of retinal microglia in experimental proliferative vitreoretinopathy
71. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases
72. Factors related to subretinal proliferation in patients with primary rhegmatogenous retinal detachment
73. Production and accumulation of thrombospondin-1 in human RPE
74. Risk factors for proliferative vitreoretinopathy
75. Immunohistochemical study of cellular fibronectin in preretinal membranes
76. Retinal pigment epithelial cell proliferation: Potentiation by monocytes and serum
77. Retinal pigment epithelium cells promote the maturation of monocytes to macrophages in vitro
78. Proliferative vitreoretinopathy: An overview
79. Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR)
80. Les etapes de la proliferation cellulaire dans un modele experimental de proliferation vitreoretinienne secondaire a l'injection de plasma enrichi en plaquettes
81. Myofibrosblasts and retinal fibrovascular membranes
82. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy
83. Primary vitrectomy for rhegmatogenous retinal detachment: An analysis of failure
84. Posibilidad de predecir el riesgo de una vitreoretinopatía proliferante mediante el análisis de factores clínicos de los desprendimientos de retina regmatógenos
85. Traction retinal detachment
86. Inhibition of proliferation of retinal pigment epithelium in vitro: Vitamin A pharmacodynamics I
87. Proliferative vitreoretinopathy: A natural history of the fellow eye
88. Shaken not stirred. Guest editorial
89. Matrix metalloproteinase biology applied to vitreal disorders
90. Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels
91. Cloning and expression of murine SC1, a gene product homologous to SPARC
92. Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein
93. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epithelial cells
94. Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases
95. Subretinal "napkin-ring" membrane in proliferative vitreoretinopathy
96. The classification of retinal detachment with proliferative vitreoretinopathy
97. Morphological and pathogenetic aspects of proliferative vitreo-retinopathy
98. Proliferative retinal diseases: Myofibroblasts cause chronic vitreoretinal traction
99. Subretinal fibrosis in retinal detachment
100. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor
101. Proliferative vitreoretinopathy. Is it anything more than wound healing at the wrong place?
102. Vitronectin and proliferative intraocular disorders. A co-localisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy
103. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration
104. The pathophysiology of proliferative vitreoretinopathy
105. Wound healing
106. Relationship between outcome of proliferative vitreoretinopathy results of tissue culture of excised preretinal membranes
107. Population and proportion of component cells in preretinal membranes
108. Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy
109. Facteurs de risque de PVR sévère postopératoire dans les déchirures géantes
110. Genistein produces reduction in growth and induces apoptosis of rat RPE-J cells
111. Induction of interleukin-8 in human retinal pigment epithelial cells after denuding injury
112. Comparative study of clinical factors predisposing patients to proliferative vitreoretinopathy